KUALA LUMPUR (July 7): Malaysian firm Yong Tai Bhd, which has partnered China-based Shenzhen Kangtai Biological Products Co Ltd (SZKT) to supply Chinese-produced Covid-19 vaccine in Malaysia, is targeting to offer its vaccines to private sector by September or October. Boo is also confident that the vaccine developed by SZKT will be well accepted as it is of the same technology platform as the other two Chinese Covid-19 vaccine developers Sinopharm and Sinovac. He noted that the technology of the Chinese vaccine is the inactivated virus vaccine, which has a good track record and has been accepted by most people. Malaysia's regulators have given conditional approval to two Chinese Covid-19 vaccines developed by Sinovac and CanSino respectively and the two vaccines are included in the country's national vaccination programme. Chinese vaccines are gaining momentum in Malaysia with more Malaysian firms jumping on Chinese vaccine distribution bandwagon.

Source: The Edge Markets July 07, 2021 03:56 UTC